A case of Aripiprazole and extra pyramidal side effects
- 9 January 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 20 (4), 592-593
- https://doi.org/10.1177/0269881106060194
Abstract
This is a case report of a 56-year-old lady who was admitted to a psychiatric ward because she was showing a plethora of positive and negative symptoms of schizophrenia. She has a positive history of mental illness; her mother had a diagnosis of schizophrenia. The patient did not have any medical history of relevance and was not taking any medication. She was commenced on Aripiprazole and after 5 weeks developed disabling extra-pyramidal side effects. On discontinuation of Aripiprazole, the side effects subsided and disappeared quickly. According to the authors’ knowledge, this is the first case of a patient developing extra-pyramidal side effects following treatment with Aripiprazole, not previously exposed to other antipsychotic, and with no co-morbid medical conditions. The authors suggest titrating Aripiprazole slowly.Keywords
This publication has 9 references indexed in Scilit:
- Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 PatientsThe Journal of Clinical Psychiatry, 2005
- Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust PharmacologyCNS Drug Reviews, 2004
- Severe Extrapyramidal Symptoms in a 3-Year-Old Boy After Accidental Ingestion of the New Antipsychotic Drug AripiprazolePediatrics, 2004
- Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect ProfileJournal of Psychopharmacology, 2004
- Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brainEuropean Journal of Pharmacology, 2004
- Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClinical Therapeutics, 2004
- ARIPIPRAZOLE AND EXTRAPYRAMIDAL SYMPTOMSJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Reactive species formed on proteins exposed to singlet oxygenPhotochemical & Photobiological Sciences, 2003
- Aripiprazole: profile on efficacy and safetyExpert Opinion on Pharmacotherapy, 2002